Zum Inhalt springen
Home » ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences in June:

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences